QAZCOVID-IN®- COVID-19 inactivated vaccine

N/A

Report date: 2022/05/17 17:45:21

Base Information

Drug NameQAZCOVID-IN®- COVID-19 inactivated vaccine
Drug Alias NameQazCovid-in® (inactivated) VaccineQazCovid-in
ClassificationVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Drug-Related Side Effects and Adverse Reactions
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryKazakhstan
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesResearch Institute For Biological Safety Problems
China Registration ClassN/A

Develop Information

Active CompaniesResearch Institute For Biological Safety Problems
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Drug-Related Side Effects and Adverse Reactions
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A